CITY COUNCIL OF THE CITY OF SAN DIEGO
SPECIAL CLOSED SESSION AGENDA
FOR
MONDAY, JANUARY 29, 2024,
CITY ADMINISTRATION BUILDING
COMMITTEE ROOM – 12TH FLOOR
202 “C” STREET
SAN DIEGO, CA 92101
_________________
NOTE: In accordance with the San Diego City Council Permanent Rules for Noticing and Conduct of Closed Session Meetings, adopted by Resolution No. R-310153 on December 8, 2015, a portion of the regular open meeting agenda of the City Council has been reserved for City Attorney comment, public comment, and City Council discussion of the content of this Closed Session Agenda. Public testimony for this Special Closed Session Agenda will be taken today during the 10:00 a.m. Council meeting.
Conference with Legal Counsel – Existing Litigation, pursuant to California Government Code Section 54956.9(d)(1):
SCS-1 U.S. Food and Drug Administration, et al. v. Alliance for Hippocratic Medicine, et al.
United States Supreme Court Case No. 23-235 & 236
Risk Management Department Claim File No. N/A
ACA Assigned: M. Travis Phelps
This case involves a challenge to the U.S. Food and Drug Administration (FDA) authorization of mifepristone, one of two drugs most commonly used for medication abortion. This past summer, the Fifth Circuit issued a ruling (currently on hold) that would threaten access across the country. In December, the United States Supreme Court agreed to review the Fifth Circuit decision, which invalidated certain authorized uses of mifepristone by the FDA. The City Attorney’s Office will present to the Mayor and City Council an opportunity to participate in this litigation as amicus curiae in support of Petitioners who are seeking to reverse the Fifth Circuit decision.